Short-term anti-ischemic effect of 17β-estradiol in postmenopausal women with coronary artery disease

Circulation

Volumn 96, Issue 9, 1997, Pages 2837-2841

  Rosano, Giuseppe M C ^a,c   Caixeta, Adriano Mendes ^d   Chierchia, Sergio ^a   Arie, Siguemituzo ^d   Lopez Hidalgo, Miguel ^d   Pereira, Wagner I ^d   Leonardo, Filippo ^a   Webb, Carolyn M ^b   Pileggi, Fulvio ^d   Collins, Peter ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c IRCCS SAN RAFFAELE PISANA   (Italy)

^d NONE

Author keywords

Coronary disease; Estrogen; Hormones; Ischemia; Women

Indexed keywords

ESTRADIOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; DRUG EFFECT; ESTROGEN ACTIVITY; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HEART PACING; HUMAN; PH; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 0030696152     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.9.2837     Document Type: Article

References (33)

1. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987;316:1105-1110.
2. Kannel WB, Hjortland MC, Mcnamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med. 1976;85:447-452.
3. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987;75:1102-1109.
4. Rosano GMC, Sarrel PM, Poole-Wilson PA, Collins P. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet. 1993;342:133-136.
5. Reis SE, Gloth ST, Blumenthal RS, Resar JR, Zacur HA, Gerstenblith G, Brinker JA. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation. 1994;89:52-60.
6. Gilligan DM, Quyyumi AA, Cannon RO III. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation. 1994;89:2545-2551.
7. Collins P, Rosano GMC, Sarrel PM, Ulrich L, Adamopoulos S, Beale CM, McNeill J, Poole-Wilson PA. Estradiol-17β attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation. 1995;92:24-30.
8. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO III. Acute vascular effects of estrogen in postmenopausal women. Circulation. 1994;90:786-791.
9. Volterrani M, Rosano GMC, Coats A, Beale C, Collins P. Estrogen acutely increases peripheral blood flow in postmenopausal women. Am J Med. 1995;99:119-122.
10. Lieberman EH, Gerhard MD, Uehata A, Walsh BW, Selwyn AP, Ganz P, Yeung AC, Creager MA. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med. 1994;121:936-941.
11. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA. 1994;91:5212-5216.
12. Sudhir K, Jennings GL, Funder JW, Komesaroff PA. Estrogen enhances basal nitric oxide release in the forearm vasculature in perimenopausal women. Hypertension. 1996;28:330-334.
13. 2+ in guinea-pig isolated cardiac myocytes. Br J Pharmacol. 1992;106:739-745.
14. 2 in porcine coronary artery. Circulation. 1995;91:2619-2626.
15. Collins P, Rosano GMC, Jiang C, Lindsay D, Sarrel PM, Poole-Wilson PA. Hypothesis: cardiovascular protection by oestrogen: a calcium antagonist effect? Lancet. 1993;341:1264-1265.
16. Jiang C, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro. Br J Pharmacol. 1991;104:1033-1037.
17. Chester AH, Jiang C, Borland JA, Yacoub MH, Collins P. Estrogen relaxes human epicardial coronary arteries through non-endothelium-dependent mechanisms. Coron Artery Dis. 1995;6:417-422.
18. Sudhir K, Chou TM, Mullen WL, Hausmann D, Collins P, Yock PG, Chatterjee K. Mechanisms of estrogen-induced vasodilation: in vivo studies in canine coronary conductance and resistance arteries. J Am Coll Cardiol. 1995;26:807-814.
19. Cobbe SM, Poole-Wilson PA. Continuous coronary sinus and arterial pH monitoring during pacing-induced ischaemia in coronary artery disease. Br Heart J. 1982;47:369-374.
20. Cobbe SM, Parker DJ, Poole-Wilson PA. Tissue and coronary venous pH in ischemic canine myocardium. Clin Cardiol. 1982;5: 153-156.
21. Cobbe SM, Poole-Wilson PA. Catheter tip pH electrodes for continuous intravascular recording. J Med Eng Technol. 1980;4:122-124.
22. Rosano GMC, Kaski JC, Arie S, Pereira WI, Horta P, Collins P, Pileggi F, Poole-Wilson PA. Failure to demonstrate myocardial ischaemia in patients with angina and normal coronary arteries: evaluation by continuous coronary sinus pH monitoring and lactate metabolism. Eur Heart J. 1996;17:1175-1180.
23. Elliott PM, Rosano GMC, Gill JS, Poole-Wilson PA, Kaski JC, McKenna WJ. Changes in coronary sinus pH during dipyridamole stress in patients with hypertrophic cardiomyopathy. Heart. 1996; 75:179-183.
24. Hardy SP, Valverde MA. Novel plasma membrane action of estrogen and antiestrogens revealed by their regulation of a large conductance chloride channel. FASEB J. 1994;8:760-765.
25. White RE, Darkow DJ, Lang JL. Estrogen relaxes coronary arteries by opening BKCa channels through a cGMP-dependent mechanism. Circ Res. 1995;77:936-942.
26. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A. 1996;93:5925-5930.
27. Botting R, Vane JR. The receipt and dispatch of chemical messengers by endothelial cells. In: Schrör K, Sinzinger H, eds. Prostaglandins in Clinical Research: Cardiovascular System. New York, NY: Alan R. Liss Inc; 1989:1-11.
28. Cheng DY, Gruetter CA. Chronic estrogen alters contractile responsiveness to angiotensin II and norepinephrine in female rat aorta. Eur J Pharmacol. 1992;215:171-176.
29. Jiang C, Sarrel PM, Poole-Wilson PA, Collins P. Acute effect of 17β-estradiol on rabbit coronary artery contractile responses to endothelin-1. Am J Physiol. 1992;263:H271-H275.
30. Venkov CD, Rankin AB, Vaughan DE. Identification of authentic estrogen receptor in cultured endothelial cells: a potential mechanism for steroid hormone regulation of endothelial function. Circulation. 1996;94:727-733.
31. Kim-Schulze S, McGowan KA, Hubchak SC, Cid MC, Martin MB, Kleinman HK, Greene GL, Schnaper W. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation. 1996;94:1402-1407.
32. Van Buren G, Yang D, Clark KE. Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol. 1992;16:828-833.
33. Tagawa H, Tagawa T, Shimokawa H. Estrogen acutely improves both nitric oxide-mediated and non nitric oxide-mediated endothelium-dependent vasodilation in postmenopausal women. Circulation. 1995;92(suppl I):I-68. Abstract.